Dr. Madhusudhanan Narasimhan

UT Southwestern Medical Center (Pathology), USA

Email: [email protected]

Qualifications

1999-2003 Ph.D., University of Madras, Taramani Campus, India

1996-1998 M.Sc., Annamalai University, Chidambaram, India

1993-1996 B. Sc, University of Madras, Chennai, India

Publications(Selected)

1. Sataranatarajan, K., Narasimhan, M., Chuckaree, I.D., Balani, J., Zhang, R. and others. Revisiting High-Sensitivity Cardiac Troponin Abnormal Baseline Cutoffs: Implications for AMI Diagnosis in the Emergency Department. Journal of Clinical Medicine, 14(20), 7308, 2025.
2. Narasimhan, M., Smith, K., Adhikari, S. and Muthukumar, A. A-397 Creatinine Chaos: When Numbers Fail, Imaging Freezes. Clinical Chemistry, 71(Supplement_1), hvaf086.381, 2025.
3. Yeo, C.L., Fankhauser, K., Muthukumar, A., Cao, J. and Narasimhan, M. B-192 Comparative evaluation of three extraction procedures for whole blood phosphatidyl ethanol analysis by liquid chromatography tandem mass spectrometry. Clinical Chemistry, 71(Supplement_1), hvaf086.585, 2025.
4. Narasimhan, M., Smith, K. and Muthukumar, A. Navigating an unexpected creatinine result during a pre-intravenous contrast renal function workup. Clinical Biochemistry, 110979, 2025.
5. Narasimhan, M., Jaleta, K., Adhikari, S., Berihun, M., SataraNatarajan, K. and others. Recent Recall of Iron Reagent—Investigation of Potential Reagent Contamination and Assay Improvement Strategy. The Journal of Applied Laboratory Medicine, 9(6):1040-1052, 2024.
6. Narasimhan, M., Jaleta, K., Adhikari, S., Berihun, M., SataraNatarajan, K. and others. A-115 Iron assay improvement: The need for thiourea addition in Ferene/Ferrozine reagent cartridge. Clinical Chemistry, 70(Supplement_1), hvae106.114, 2024.
7. Narasimhan, M., Jones, P.M., Poling, A., Jones, V., Fisher, S. and others. B-275 Trends of urine drug testing findings in a pediatric hospital from 2019 to 2023. Clinical Chemistry, 70(Supplement_1), hvae106.632, 2024.
8. Sataranatarajan, K., Adhikari, S., Nguyen, N., Narasimhan, M., Balani, J. and others. Performance Evaluation of Open Channel Buhlmann Fecal Calprotectin Turbo Assay on Abbott Alinity C Analyzer. Diagnostics, 14(16), 1744, 2024.
9. Narasimhan, M., Jaleta, K., Adhikari, S., Berihun, M., Sataranatarajan, K. and others. Iron assay reagent recall over positive bias results: A critical analysis and potential solution. Clinica Chimica Acta, 558, 119783, 2024.
10. Narasimhan, M., Muthukumar, A., Sataranatarajan, K., Mahimainathan, L. and others. Crossroads between Autoimmunity and COVID-19 in Lung Transplant Recipients. Viruses, 15(10), 2045, 2023.
11. Narasimhan, M., Kim, K., Mahimainathan, L., Zhang, R., Malladi, S. and others. B-063 Towards Improving mRNA Vaccine Effectiveness in Immunosuppressed Adults: Elucidating the Mechanisms and Evaluating Potential Improvement Strategies. Clinical Chemistry, 69(Supplement_1), hvad097.403, 2023.
12. Muthukumar, A., Narasimhan, M. and Luo, R. Advancing the understanding of emergence of SARS-CoV-2 genetic variants and COVID-19 vaccine efficacy: Essential clinical and molecular insights and breakthroughs. Frontiers Media SA, 2023.
13. Shanmugam, S., Patel, D., Rodriguez, A.L., Walchale, A., Liu, X. and others. Ethanol inhibition of undifferentiated rat neural progenitor cell replication can be prevented by chlorogenic acid via the NFATc4/CSE signaling pathway. Alcohol: Clinical and Experimental Research, 47(8):1530-1543, 2023.
14. Sannareddy, A., Reves, H., Jaleta, K., Ramiahsankarasubramanian, R. and others. Do Monoclonal Antibody Therapies Improve 'Real-World' Outcomes of COVID-19 in Patients with Lymphoid Malignancies? the UT Southwestern Experience. Blood, The Journal of the American Society of Hematology, 140(Supplement 1), 2022.
15. Moeller, M., Thulasingam, S., Stanke, K.M., Narasimhan, M. and Kidambi, S. Stiffness Promotes Metabolic Reprogramming in Primary Hepatocytes. 2022 AIChE Annual Meeting, 2022.
16. Kim, K., Narasimhan, M., Mahimainathan, L., Zhang, R., Araj, E. and others. Translation suppression underlies the restrained COVID-19 mRNA vaccine response in the high-risk immunocompromised group. Frontiers in immunology, 13, 1020165, 2022.
17. Lueking, R., Clark, A.E., Narasimhan, M., Mahimainathan, L., Muthukumar, A. and others. SARS-CoV-2 coinfections with variant genomic lineages identified by multiplex fragment analysis. Frontiers in genetics, 13, 942713, 2022.

Personal Details

https://scholar.google.com/citations?user=XLAR_FwAAAAJ&hl=en

https://www.researchgate.net/profile/Madhusudhanan-Narasimhan

WoS Researcher ID: DHH-3638-2022